Table II.
Epidemiological data on HIV, HCV and HBV screening in the SSP setting 2010–2013.
| Country | First-time donations | Repeat donations | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| N. of donations | HIV | HCV | HBV | N. of donations | HIV | HCV | HBV | ||||
| Total (prev./105) | Recent (prev./105) | Total (prev. /105) | Recent (prev./105) | Total (prev. /105) | Recent (prev./105) | Total (prev./105) | Total (prev. /105) | Total (prev./105) | |||
| Austria | 209,761 | 8 (3.8) | 1 (0.5) | 60 (28.6) | 0 (0.0) | 122 (58.2) | 5 (2.4) | 1,363,102 | 16 (1.2) | 16 (1.2) | 5 (0.4) |
| Belgium | 186,389 | 8 (4.3) | 0 (0.0) | 73 (39.2) | 1 (0.5) | 176 (94.4) | 1 (0.5) | 2,095,733 | 16 (0.8) | 5 (0.2) | 10 (0.5) |
| Bulgaria# | 138,303 | 17 (12.3) | NA | 350 (253.1) | NA | 2,090 (1,511.2) | NA | 531,571 | 13 (2.4) | 465 (87.5) | 2,842 (534.6) |
| Croatia | 49,170 | 4 (8.1) | 0 (0.0) | 32 (65.1) | 0 (0.0) | 52 (105.8) | 6 (12.2) | 666,979 | 7 (1.0) | 13 (1.9) | 31 (4.6) |
| Cyprus# | 36,870 | 6 (16.3) | 0 (0.0) | 9 (24.4) | 0 (.0) | 18 (48.8) | 0 (0.0) | 73,649 | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Czech Rep† | 113,576 | 7 (6.2) | NA | 80 (70.4) | NA | 43 (37.9) | NA | 1,519,471 | 10 (10.7) | 17 (1.1) | 27 (1.8) |
| Denmark | 91,375 | 1 (1.1) | 0 (0.0) | 11 (12.0) | 0 (0.0) | 26 (28.5) | 4 (4.4) | 1,188,770 | 3 (0.2) | 2 (0.2) | 9 (0.8) |
| Estonia | 31,074 | 12 (38.6) | 1 (3.2) | 157 (505.2) | 0 (0.0) | 34 (109.4) | 0 (0.0) | 206,640 | 10 (4.8) | 27 (13.1) | 13 (6.3) |
| Finland | 70,409 | 1 (1.4) | 0 (0.0) | 24 (34.1) | 0 (0.0) | 3 (4.3) | 0 (0.0) | 947,744 | 3 (0.3) | 15 (1.6) | 5 (0.5) |
| France | 1,770,492 | 49 (2.8) | NA | 466 (26.3) | NA | 948 (53.5) | NA | 10,402,304 | 70 (0.7) | 51 (0.5) | 36 (0.3) |
| Germany* | 553,992 | 39 (7.0) | 0 (0.0) | 278 (50.2) | 0 (0.0) | 618 (111.6) | 0 (0.0) | 7,242,799 | 72 (1.0) | 35 (0.5) | 23 (0.3) |
| Hungary# | 175,375 | 9 (5.1) | NA | 371 (211.5) | NA | 350 (1,99.6) | NA | 1,520,124 | 47 (3.1) | 93 (6.1) | 42 (2.8) |
| Ireland (a) | 45,643 | 1 (2.2) | 0 (0.0) | 2 (4.4) | 0 (0.0) | 5 (11.0) | 0 (0.0) | 540,506 | 1 (0.2) | 0 (0.0) | 0 (0.0) |
| Italy (a) | 1,137,695 | 163 (14.3) | 0 (0.0) | 1,029 (90.4) | 13 (1.1) | 2,054 (180.5) | 39 (3.4) | 11,098,098 | 263 (2.4) | 136 (1.2) | 550 (4.9) |
| Latvia | 43,883 | 32 (72.9) | 1 (2.3) | 733 (1,670.4) | 5 (11.4) | 245 (558.3) | 1 (2.3) | 173,310 | 16 (9.2) | 159 (91.7) | 14 (8.1) |
| Lithuania | 49,818 | 24 (48.2) | 0 (0.0) | 710 (1,425.2) | 13 (26.1) | 269 (540.0) | 7 (14.1) | 106,120 | 20 (18.8) | 156 (147.0) | 24 (22.6) |
| Luxembourg | 5,110 | 0 (0.0) | 0 (0.0) | 4 (78.3) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 89,288 | 1 (1.1) | 0 (0.0) | 0 (0.0) |
| MaltaƗ | 8,651 | 0 (0.0) | 0 (0.0) | 4 (46.2) | 0 (0.0) | 7 (80.9) | 0 (0.0) | 57,853 | 0 (0.0) | 1 (1.7) | 0 (0.0) |
| Poland | 755,270 | 92 (12.2) | 0 (0.0) | 2,371 (313.9) | 6 (0.8) | 3,293 (436.0) | 2 (0.3) | 4,083,694 | 99 (2.4) | 190 (4.6) | 82 (2.0) |
| Portugal | 83,466 | 57 (68.3) | 1 (1.2) | 134 (160.5) | 0 (0.0) | 113 (135.4) | 6 (7.2) | 670,363 | 117 (17.4) | 270 (40.3) | 76 (11.3) |
| Romania# | 281,235 | 122 (43.4) | NA | 1,565 (556.5) | NA | 8,609 (3,061.1) | NA | 936,546 | 44 (4.7) | 35 (3.7) | 116 (12.4) |
| Slovakia# | 100,041 | 4 (4.0) | NA | 43 (43.0) | NA | 74 (74.0) | NA | 537,415 | 1 (0.2) | 20 (3.7) | 6 (1.1) |
| Slovenia | 31,570 | 1 (3.2) | 0 (0.0) | 8 (25.3) | 0 (0.0) | 32 (101.4) | 0 (0.0) | 335,144 | 7 (2.1) | 0 (0.0) | 29 (8.6) |
| Spain | 709,925 | 187 (26.3) | 13 (1.8) | 722 (101.7) | 7 (1.0) | 1,301 (183.3) | 242 (34.1) | 4,694,645 | 269 (5.7) | 77 (1.6) | 235 (5.0) |
| Switzerland | 110,019 | 4 (3.6) | 1 (0.9) | 63 (57.3) | 0 (0.0) | 130 (118.2) | 12 (10.9) | 1,342,991 | 8 ( 0.6) | 7 (0.5) | 16 (1.2) |
| England/ Wales/ Northern Ireland | 658,305 | 31 (4.7) | 0.0 | 225 (34.2) | 0 (0.0) | 256 (38.9) | 4 (0.6) | 7,560,945 | 31 (0.4) | 20 (0.3) | 17 (0.2) |
| Total | 7,447,417 | 879 (11.8) | NA | 9,524 (127.9) | NA | 20,868 (228.2) | NA | 59,976,162 | 1,144 (1.9) | 1,810 (3.0) | 4,208 (7.0) |
NA: not available;
*
Data from three blood establishments; #donations not tested with NAT;
†
donations tested in a few blood establishments; prev.: prevalence; (a) standard selection strategy not used in the whole country or for all types of donors. HIV: human immunodeficiency virus; HCV: hepatitis C virus; HBV: hepatitis B virus; SSP: standard selection procedure.